Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial.
暂无分享,去创建一个
S B Soumerai | J. Gurwitz | E. Guadagnoli | R. Asinger | S. Soumerai | D. Willison | T. Mclaughlin | E Guadagnoli | J H Gurwitz | T J McLaughlin | P. Hauptman | Xiaoming Gao | C. Borbas | N. Morris | B. McLaughlin | X. Gao | F. Gobel | D J Willison | P J Hauptman | X Gao | C Borbas | N Morris | B McLaughlin | R Asinger | F Gobel | Fredarick Gobel
[1] ISIS-1 Collaborative Group. RANDOMISED TRIAL OF INTRAVENOUS ATENOLOL AMONG 16 027 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-1 , 1986, The Lancet.
[2] D. Berwick. Quality of health care. Part 5: Payment by capitation and the quality of care. , 1996, The New England journal of medicine.
[3] G. Bole,et al. Evaluation of a continuing education program in rheumatoid arthritis. , 1980, Arthritis and rheumatism.
[4] S B Soumerai,et al. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions. , 1984, The Milbank Memorial Fund quarterly. Health and society.
[5] S Greenfield,et al. The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement: Comorbidity and Outcomes After Hip Replacement , 1993, Medical care.
[6] J. Eisenberg,et al. Changing physicians' practices. , 1993, Tobacco control.
[7] N. Laird,et al. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. , 1989, Archives of internal medicine.
[8] R. Hiss,et al. Continuing education in pulmonary disease for primary-care physicians. , 2015, The American review of respiratory disease.
[9] S B Soumerai,et al. Principles of educational outreach ('academic detailing') to improve clinical decision making. , 1990, JAMA.
[10] J. Gurwitz,et al. Consultation between cardiologists and generalists in the management of acute myocardial infarction: implications for quality of care. , 1998, Archives of internal medicine.
[11] J. Gurwitz,et al. Coronary thrombolysis for the elderly? , 1991, JAMA.
[12] F. Klocke,et al. Guidelines for the early management of patients with acute myocardial infarction , 1990 .
[13] E. McGlynn,et al. Measuring Quality of Care , 1996 .
[14] Richard P. Lewis,et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[15] J. Kassirer,et al. Quality and the medical marketplace--following elephants. , 1996, The New England journal of medicine.
[16] Eugene Vayda,et al. Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section. , 1991, JAMA.
[17] J. Gurwitz,et al. Delayed Hospital Presentation in Patients Who Have Had Acute Myocardial Infarction , 1997, Annals of Internal Medicine.
[18] Elizabeth C. Hirschman,et al. Judgment under Uncertainty: Heuristics and Biases , 1974, Science.
[19] S. Yusuf,et al. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials. , 1990, Circulation.
[20] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[21] B. McNeil,et al. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. , 1994, Journal of the American College of Cardiology.
[22] Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. , 1997, JAMA.
[23] A D Oxman,et al. Changing physician performance. A systematic review of the effect of continuing medical education strategies. , 1995, JAMA.
[24] A L Greer,et al. The State of the Art Versus the State of the Science: The Diffusion of New Medical Technologies into Practice , 1988, International Journal of Technology Assessment in Health Care.
[25] E. Antman,et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. , 1996, Archives of internal medicine.
[26] H. Krumholz,et al. Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. , 1995, JAMA.
[27] R. Collins,et al. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. , 1997, The New England journal of medicine.
[28] M. Chassin. Quality of health care. Part 3: improving the quality of care. , 1996, The New England journal of medicine.
[29] J. Gurwitz,et al. Controversies Surrounding the Use of β-Blockers in Older Patients with Cardiovascular Disease , 1994, Drugs & aging.
[30] D Blumenthal,et al. Quality of health care. Part 4: The origins of the quality-of-care debate. , 1996, The New England journal of medicine.
[31] J. Avorn,et al. Improving drug prescribing in primary care: a critical analysis of the experimental literature. , 1989, The Milbank quarterly.
[32] J Lomas,et al. Evaluating the Message: The Relationship Between Compliance Rate and the Subject of a Practice Guideline , 1994, Medical care.
[33] J. Gurwitz,et al. Coronary thrombolysis for the elderly. Is clinical practice really lagging behind evidence of benefit? , 1997, JAMA.
[34] R. Holman,et al. Cost-effectiveness analysis of a rotavirus immunization program for the United States. , 1995, JAMA.
[35] Dwight Lemon,et al. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 , 1987 .